Oppenheimer Reiterates Outperform Rating on Imperva (IMPV) Following Strong Q4

February 9, 2017 6:24 AM EST Send to a Friend
Oppenheimer analyst Shaul Eyal reiterates Outperform rating and $55 price target on Imperva Inc. (NYSE: IMPV), as the company reported ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login